Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher D Goodman

Showing results (61-70 of 64) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 64 results.
JAMA Oncology|March 7, 2024
Stereotactic Radiation Therapy in Early Non-Small Cell Lung Cancer and Interstitial Lung Disease: A Nonrandomized Clinical TrialDavid A Palma, Houda Bahig, Andrew Hope, et al.
BMC Palliative Care|September 7, 2024
A randomized phase III trial of stereotactic ablative radiotherapy for patients with up to 10 oligometastases and a synchronous primary tumor (SABR-SYNC): study protocolDavid A Palma, Meredith E Giuliani, Rohann J M Correa, et al.
Research Square|July 18, 2025
Potent Acridone Antimalarial against All Three Life Stages of <i>Plasmodium</i>Papireddy Kancharla, Rozalia A Dodean, Yuexin Li, et al.
Nature Communications|April 14, 2026
Potent acridone antimalarial against all three life stages of PlasmodiumPapireddy Kancharla, Rozalia A Dodean, Yuexin Li, et al.
Pageof 7

Showing results (61-70 of 64) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 64 results.
JAMA Oncology|March 7, 2024
Stereotactic Radiation Therapy in Early Non-Small Cell Lung Cancer and Interstitial Lung Disease: A Nonrandomized Clinical TrialDavid A Palma, Houda Bahig, Andrew Hope, et al.
BMC Palliative Care|September 7, 2024
A randomized phase III trial of stereotactic ablative radiotherapy for patients with up to 10 oligometastases and a synchronous primary tumor (SABR-SYNC): study protocolDavid A Palma, Meredith E Giuliani, Rohann J M Correa, et al.
Research Square|July 18, 2025
Potent Acridone Antimalarial against All Three Life Stages of <i>Plasmodium</i>Papireddy Kancharla, Rozalia A Dodean, Yuexin Li, et al.
Nature Communications|April 14, 2026
Potent acridone antimalarial against all three life stages of PlasmodiumPapireddy Kancharla, Rozalia A Dodean, Yuexin Li, et al.
Pageof 7